Selected research
Industry Research
Cinnarizine Tablets Industry Research Report 2026
Market perspective
The global Cinnarizine Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cinnarizine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cinnarizine Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cinnarizine Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cinnarizine Tablets include Actavis, Bristol Myers Squibb, Glenmark Pharmaceuticals, Johnson & Johnson, McNeil Products, Peak Pharmacy, Sanofi, Teva Pharmaceuticals and Torrent Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cinnarizine Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cinnarizine Tablets Market by Company
Actavis
Bristol Myers Squibb
Glenmark Pharmaceuticals
Johnson & Johnson
McNeil Products
Peak Pharmacy
Sanofi
Teva Pharmaceuticals
Torrent Pharmaceuticals
Beijing Neptunus Zhongxin Pharmaceutical
Cisen Pharma
Harbin Pharmaceutical Group
Nanjing Baijingyu Pharmaceutical
Shanghai Xinyi Wanxiang Pharmaceutical
CSPC
Cinnarizine Tablets Segment by Type
15mg per Tablet
25mg per Tablet
Cinnarizine Tablets Segment by Application
Hospital and Clinic
Retail Pharmacies
Other
Cinnarizine Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cinnarizine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cinnarizine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cinnarizine Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cinnarizine Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cinnarizine Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cinnarizine Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 15mg per Tablet
- 25mg per Tablet
Applications
- Hospital and Clinic
- Retail Pharmacies
- Other
Companies covered
- Actavis
- Bristol Myers Squibb
- Glenmark Pharmaceuticals
- Johnson & Johnson
- McNeil Products
- Peak Pharmacy
- Sanofi
- Teva Pharmaceuticals
- Torrent Pharmaceuticals
- Beijing Neptunus Zhongxin Pharmaceutical
- Cisen Pharma
- Harbin Pharmaceutical Group
- Nanjing Baijingyu Pharmaceutical
- Shanghai Xinyi Wanxiang Pharmaceutical
- CSPC
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cinnarizine Tablets Market Size (2021-2032)
- 2.2.2 Global Cinnarizine Tablets Sales (2021-2032)
- 2.2.3 Global Cinnarizine Tablets Market Average Price (2021-2032)
- 2.3 Cinnarizine Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 15mg per Tablet
- 2.3.3 25mg per Tablet
- 2.4 Cinnarizine Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital and Clinic
- 2.4.3 Retail Pharmacies
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cinnarizine Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cinnarizine Tablets Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Cinnarizine Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Cinnarizine Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Cinnarizine Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cinnarizine Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cinnarizine Tablets, Product Type & Application
- 3.8 Global Manufacturers of Cinnarizine Tablets, Established Date
- 3.9 Global Cinnarizine Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Actavis
- 4.1.1 Actavis Company Information
- 4.1.2 Actavis Business Overview
- 4.1.3 Actavis Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Actavis Cinnarizine Tablets Product Portfolio
- 4.1.5 Actavis Recent Developments
- 4.2 Bristol Myers Squibb
- 4.2.1 Bristol Myers Squibb Company Information
- 4.2.2 Bristol Myers Squibb Business Overview
- 4.2.3 Bristol Myers Squibb Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bristol Myers Squibb Cinnarizine Tablets Product Portfolio
- 4.2.5 Bristol Myers Squibb Recent Developments
- 4.3 Glenmark Pharmaceuticals
- 4.3.1 Glenmark Pharmaceuticals Company Information
- 4.3.2 Glenmark Pharmaceuticals Business Overview
- 4.3.3 Glenmark Pharmaceuticals Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Glenmark Pharmaceuticals Cinnarizine Tablets Product Portfolio
- 4.3.5 Glenmark Pharmaceuticals Recent Developments
- 4.4 Johnson & Johnson
- 4.4.1 Johnson & Johnson Company Information
- 4.4.2 Johnson & Johnson Business Overview
- 4.4.3 Johnson & Johnson Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Johnson & Johnson Cinnarizine Tablets Product Portfolio
- 4.4.5 Johnson & Johnson Recent Developments
- 4.5 McNeil Products
- 4.5.1 McNeil Products Company Information
- 4.5.2 McNeil Products Business Overview
- 4.5.3 McNeil Products Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 McNeil Products Cinnarizine Tablets Product Portfolio
- 4.5.5 McNeil Products Recent Developments
- 4.6 Peak Pharmacy
- 4.6.1 Peak Pharmacy Company Information
- 4.6.2 Peak Pharmacy Business Overview
- 4.6.3 Peak Pharmacy Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Peak Pharmacy Cinnarizine Tablets Product Portfolio
- 4.6.5 Peak Pharmacy Recent Developments
- 4.7 Sanofi
- 4.7.1 Sanofi Company Information
- 4.7.2 Sanofi Business Overview
- 4.7.3 Sanofi Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Sanofi Cinnarizine Tablets Product Portfolio
- 4.7.5 Sanofi Recent Developments
- 4.8 Teva Pharmaceuticals
- 4.8.1 Teva Pharmaceuticals Company Information
- 4.8.2 Teva Pharmaceuticals Business Overview
- 4.8.3 Teva Pharmaceuticals Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Teva Pharmaceuticals Cinnarizine Tablets Product Portfolio
- 4.8.5 Teva Pharmaceuticals Recent Developments
- 4.9 Torrent Pharmaceuticals
- 4.9.1 Torrent Pharmaceuticals Company Information
- 4.9.2 Torrent Pharmaceuticals Business Overview
- 4.9.3 Torrent Pharmaceuticals Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Torrent Pharmaceuticals Cinnarizine Tablets Product Portfolio
- 4.9.5 Torrent Pharmaceuticals Recent Developments
- 4.10 Beijing Neptunus Zhongxin Pharmaceutical
- 4.10.1 Beijing Neptunus Zhongxin Pharmaceutical Company Information
- 4.10.2 Beijing Neptunus Zhongxin Pharmaceutical Business Overview
- 4.10.3 Beijing Neptunus Zhongxin Pharmaceutical Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Beijing Neptunus Zhongxin Pharmaceutical Cinnarizine Tablets Product Portfolio
- 4.10.5 Beijing Neptunus Zhongxin Pharmaceutical Recent Developments
- 4.11 Cisen Pharma
- 4.11.1 Cisen Pharma Company Information
- 4.11.2 Cisen Pharma Business Overview
- 4.11.3 Cisen Pharma Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Cisen Pharma Cinnarizine Tablets Product Portfolio
- 4.11.5 Cisen Pharma Recent Developments
- 4.12 Harbin Pharmaceutical Group
- 4.12.1 Harbin Pharmaceutical Group Company Information
- 4.12.2 Harbin Pharmaceutical Group Business Overview
- 4.12.3 Harbin Pharmaceutical Group Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Harbin Pharmaceutical Group Cinnarizine Tablets Product Portfolio
- 4.12.5 Harbin Pharmaceutical Group Recent Developments
- 4.13 Nanjing Baijingyu Pharmaceutical
- 4.13.1 Nanjing Baijingyu Pharmaceutical Company Information
- 4.13.2 Nanjing Baijingyu Pharmaceutical Business Overview
- 4.13.3 Nanjing Baijingyu Pharmaceutical Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Nanjing Baijingyu Pharmaceutical Cinnarizine Tablets Product Portfolio
- 4.13.5 Nanjing Baijingyu Pharmaceutical Recent Developments
- 4.14 Shanghai Xinyi Wanxiang Pharmaceutical
- 4.14.1 Shanghai Xinyi Wanxiang Pharmaceutical Company Information
- 4.14.2 Shanghai Xinyi Wanxiang Pharmaceutical Business Overview
- 4.14.3 Shanghai Xinyi Wanxiang Pharmaceutical Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Shanghai Xinyi Wanxiang Pharmaceutical Cinnarizine Tablets Product Portfolio
- 4.14.5 Shanghai Xinyi Wanxiang Pharmaceutical Recent Developments
- 4.15 CSPC
- 4.15.1 CSPC Company Information
- 4.15.2 CSPC Business Overview
- 4.15.3 CSPC Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 CSPC Cinnarizine Tablets Product Portfolio
- 4.15.5 CSPC Recent Developments
5 Global Cinnarizine Tablets Market Scenario by Region
- 5.1 Global Cinnarizine Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cinnarizine Tablets Sales by Region: 2021-2032
- 5.2.1 Global Cinnarizine Tablets Sales by Region: 2021-2026
- 5.2.2 Global Cinnarizine Tablets Sales by Region: 2027-2032
- 5.3 Global Cinnarizine Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Cinnarizine Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Cinnarizine Tablets Revenue by Region: 2027-2032
- 5.4 North America Cinnarizine Tablets Market Facts & Figures by Country
- 5.4.1 North America Cinnarizine Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cinnarizine Tablets Sales by Country (2021-2032)
- 5.4.3 North America Cinnarizine Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Cinnarizine Tablets Market Facts & Figures by Country
- 5.5.1 Europe Cinnarizine Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cinnarizine Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Cinnarizine Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Cinnarizine Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cinnarizine Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cinnarizine Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cinnarizine Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cinnarizine Tablets Market Facts & Figures by Country
- 5.7.1 South America Cinnarizine Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cinnarizine Tablets Sales by Country (2021-2032)
- 5.7.3 South America Cinnarizine Tablets Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Cinnarizine Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cinnarizine Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cinnarizine Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cinnarizine Tablets Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Cinnarizine Tablets Sales by Type (2021-2032)
- 6.1.1 Global Cinnarizine Tablets Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Cinnarizine Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Cinnarizine Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Cinnarizine Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cinnarizine Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Cinnarizine Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cinnarizine Tablets Sales by Application (2021-2032)
- 7.1.1 Global Cinnarizine Tablets Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Cinnarizine Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Cinnarizine Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Cinnarizine Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cinnarizine Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Cinnarizine Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cinnarizine Tablets Value Chain Analysis
- 8.1.1 Cinnarizine Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cinnarizine Tablets Production Mode & Process
- 8.2 Cinnarizine Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cinnarizine Tablets Distributors
- 8.2.3 Cinnarizine Tablets Customers
9 Global Cinnarizine Tablets Analyzing Market Dynamics
- 9.1 Cinnarizine Tablets Industry Trends
- 9.2 Cinnarizine Tablets Industry Drivers
- 9.3 Cinnarizine Tablets Industry Opportunities and Challenges
- 9.4 Cinnarizine Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst